Intraprostatic Botulinum Toxin injection in patients with benign prostatic enlargement

Histological evidence of benign prostatic hyperplasia (BPH) exceeded 50% in men over 50 years of age and rose to 75% as men entered the eighth decade. Therapeutic options for BPH generally fall into one of the three categories: watchful waiting, medical treatment and surgery. Excluding watchful wait...

Descripción completa

Detalles Bibliográficos
Autores principales: Ilie, CP, Chancellor, MB, Chuang, YC, Mischianu, D
Formato: Texto
Lenguaje:English
Publicado: Carol Davila University Press 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3019017/
https://www.ncbi.nlm.nih.gov/pubmed/20108746

Ejemplares similares

Ejemplares similares